Evidence map›Paper›PMID 38565977›Full record

ArticleNature chemistry2024

Asymmetric photoredox catalytic formal de Mayo reaction enabled by sensitization-initiated electron transfer.

Xin Sun, Yilin Liu, Yanli Yin, Xu Ban, Xiaowei Zhao, Zhiyong Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dicyanopyrazine: 10th Anniversary in Photoredox Catalysis.Chemical record (New York, N.Y.) · 2025
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin SunKey Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan University, Kaifeng, P. R. China.ORCID http://orcid.org/0009-0005-9900-2878
Yilin LiuSchool of Chemistry and Chemical Engineering, Pingyuan Laboratory, Henan Normal University, Xinxiang, P. R. China.
Yanli YinSchool of Chemistry and Chemical Engineering, Pingyuan Laboratory, Henan Normal University, Xinxiang, P. R. China.
Xu BanKey Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan University, Kaifeng, P. R. China.
Xiaowei ZhaoKey Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan University, Kaifeng, P. R. China.
Zhiyong JiangKey Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan University, Kaifeng, P. R. China. jiangzhiyong@htu.edu.cn.ORCID http://orcid.org/0000-0002-6350-7429

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21925103National Natural Science Foundation of China (National Science Foundation of China) 22171072
6 · The paper itself

Abstract

Visible-light-driven photoredox catalysis is known to be a powerful tool for organic synthesis. Its occurrence critically depends on the twice exothermic single-electron transfer processes of photosensitizers, which are governed by the redox properties of the species involved. Hence, the inherently narrow range of redox potentials of photosensitizers inevitably constrains their further availability. Sensitization-initiated electron transfer has recently been found to effectively overcome this substantial challenge. However, feasible and practical strategies for designing such complicated catalytic systems are rather scarce. Herein we report an elaborate dual-catalyst platform, with dicyanopyrazine as a visible light photosensitizer and a pyrenyl-incorporated chiral phosphoric acid as a co-sensitizer, and we demonstrate the applicability of this sensitization-initiated electron transfer strategy in an asymmetric formal de Mayo-type reaction. The catalysis platform enables otherwise thermodynamically unfavourable electron transfer processes to close the redox cycle and allows for precise access to valuable enantioenriched 1,5-diketones with a wide substrate range.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.